Annexin-V Mapping of Cardiomyocyte Death After I/R
2026-09-09
This Circulation study introduced labeled recombinant human annexin-V as an in situ marker of phosphatidylserine exposure during myocardial ischemia and reperfusion in mice. By resolving cell-death timing and responding to pharmacological intervention, the approach provided a more actionable readout than DNA-fragmentation assays alone.
Mithramycin A: Workflow for Sp1-Linked Research
2026-09-08
Mithramycin A is an anticancer antibiotic that converts G-C-rich DNA binding into a practical perturbation strategy for transcription, c-myc, and differentiation studies. This guide connects cancer assays with the miR-24-3p/Sp1/PI3K findings from a cardiac injury model while clearly separating established evidence from assay-development recommendations.
IGF2BP1–TUBB4B Axis in Liver Fibrosis
2026-09-08
The reference study identifies an m6A-dependent IGF2BP1–TUBB4B–FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. Its combination of transcriptomic re-analysis, RNA-binding and methylation profiling, genetic perturbation, and pharmacological testing provides a useful framework for interpreting post-transcriptional mechanisms in liver fibrosis.
L1023 Anti-Cancer Compound Library for Cancer Research
2026-09-07
The L1023 Anti-Cancer Compound Library provides 1164 pre-dissolved bioactive compounds for cancer research and high-throughput screening. Its target diversity includes BRAF kinase inhibitor candidates, mTOR-related compounds, proteasome inhibitors, HDAC inhibitors, and apoptosis regulators.
Palmitic acid: Practical Protocol and QC Guide
2026-09-05
Palmitic acid (hexadecanoic acid, SKU N2456) provides a characterized saturated long-chain fatty acid input for solvent-based studies of lipid metabolism, insulin signaling, inflammation, and protein palmitoylation. It is not suitable for direct addition to aqueous systems or long-term solution storage, so solvent matching, fresh preparation, and documented QC are central to reproducible use.
Carrier-Platin and Rapid ROS Cancer Cell Death
2026-09-05
Liu and colleagues developed carrier-platin, a poly(amino acids) formulation containing ultrasmall platinum nanoparticles that rapidly elevates intracellular reactive oxygen species. The resulting cancer-cell death is distinct from conventional platinum-induced apoptosis and ferroptosis, appears independent of DNA damage, and shows activity against multidrug-resistant tumors with limited systemic toxicity in preclinical models.
BCA Protein Quantification Kit K4102
2026-09-04
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports sensitive total-protein measurement in dilute samples, including many detergent-containing biochemical preparations and cell lysates. It is intended for scientific research and sample normalization, not diagnostic, clinical, or medical testing.
Disulfiram Workflows for ALDH2 and Proteasome Research
2026-09-04
Disulfiram connects ALDH2-linked synthetic lethality with copper-associated proteasome studies, making it useful for mechanism-resolved cancer research. This practical guide covers formulation, dose selection, pathway validation, model comparison, and troubleshooting for reproducible cell-free and cell-based assays.
Palmitic acid (N2456): Protocol and QC Guide
2026-09-03
Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a characterized saturated long-chain fatty acid for lipid metabolism, insulin signaling, and inflammation-related workflows. It is intended for solvent-based preparation and prompt use, not direct aqueous dissolution or long-term storage as a solution.
Lanabecestat (AZD3293): Cell Assay Guide
2026-09-03
A scenario-based guide to using Lanabecestat (AZD3293), SKU BA8438, in neuronal, viability, proliferation, and cytotoxicity workflows. It connects product specifications with peer-reviewed evidence on partial BACE1 inhibition, amyloid-beta reduction, and synaptic-function interpretation.
Reversine for Aurora Kinase Assays
2026-09-02
Reversine is a cell-permeable Aurora kinase inhibitor for dissecting mitotic checkpoint failure, cancer cell proliferation inhibition, and apoptosis induction in cancer cells. This practical guide connects dose–response workflows with cervical cancer research and emerging single-structure phenotyping platforms.
nor-Binaltorphimine Dihydrochloride in Pain Circuits
2026-09-02
Explore how nor-Binaltorphimine dihydrochloride can convert κ-opioid receptor blockade into a precise assay variable for studying mechanical allodynia. This article translates a brain-to-spinal circuit study into practical decisions about spatial targeting, behavioral timing, controls, and compound handling.
EZ Cap™ Firefly Luciferase mRNA: Assay Guide
2026-09-01
A scenario-based guide to improving reporter-based viability, proliferation, and cytotoxicity workflows with EZ Cap™ Firefly Luciferase mRNA (5-moUTP), SKU R1013. It explains assay design, handling, normalization, delivery variables, and practical criteria for selecting a reliable modified mRNA reagent.
Partial BACE Inhibition Preserves Synaptic Function
2026-08-31
Satir et al. show that moderate β-secretase inhibition can reduce amyloid-β secretion by up to 50% without impairing synaptic transmission in primary rat cortical neurons. The study identifies a functional exposure window that separates potentially useful BACE target engagement from synaptic dysfunction caused by stronger inhibition.
LAMP1 and CXCL10–CXCR3 Macrophage Polarization
2026-08-31
The 2024 International Immunopharmacology study identifies LAMP1 as a context-dependent molecular switch linking the CXCL10–CXCR3 axis with macrophage polarization and autophagy. Its use of AMG 487 shows that CXCR3 blockade can produce opposite macrophage outcomes in non-inflammatory versus poly(I:C)-stimulated settings and reduce acute lung injury in mice.
507 records 9/34 page Previous Next First page 上5页 678910 下5页 Last page